Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Investigation of Kaletra Tablets (Quaque Die, QD) on Patients With HIV-infection

NCT01328158 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT01328158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01328158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Investigation of Kaletra Tablets (Quaque Die, QD) on Patients With HIV-infection
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2013
Enrollment
236 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus infection